28 July 2003
H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis
Peter C. Konturek, Jacek Kania, Jan W. Konturek, Agnieszka Nikiforuk, Stanisław J. Konturek, Eckhart G. HahnMed Sci Monit 2003; 9(7): SR53-66 :: ID: 13085
Abstract
Background:Helicobacter pylori (Hp) infection represents a crucial factor in pathogenesis of gastric cancer (GC). Factors emanating from bacterium as well as from environmental contributions such as salt diet and inadequate supply of antioxidants, affect the risk for GC development.Results:Atrophic gastritis is considered to be a precursor lesion of intestinal type GC that is accompanied by hypergastrinemia with subsequent induction of cyclooxygenase-2 (COX-2), whose products are responsible for slowing apoptosis and for angiogenesis in GC tumor. The involvement of proinflammatory cytokines (especially IL-1 and IL-8) and reactive oxygen species (ROS) due to NFkB activation, increased cell proliferation combined with inhibition of apoptosis as well as upregulation of peroxisome proliferation activated receptor gamma (PPARg) and inducible nitric oxide synthase (iNOS) appear to be major molecular biology alterations in pathogenesis of GC.Conclusions:These results suggest the therapeutic usefulness of inhibitors of gastrin expression and release such as powerful somatostatin analogs (Sandostatin) or blockers of COX-2 (coxibs) in the control of GC development and progression as chemopreventive agents. Comparative genomic and proteomic is the key in identifying biomarkers in host and bacterium for the prediction of gastric cancer in Hp-infected patients.
Keywords: Apoptosis - physiology, Bacterial Proteins - genetics, Bacterial Proteins - metabolism, Cyclooxygenase 2, Cytokines - metabolism, Gastrins - antagonists & inhibitors, Gastrins - genetics, Gastrins - metabolism, Gastritis, Atrophic - metabolism, Helicobacter Infections - complications, Helicobacter Infections - metabolism, Helicobacter pylori - metabolism, Isoenzymes - antagonists & inhibitors, Isoenzymes - metabolism, Membrane Proteins, Nitric Oxide Synthase - metabolism, Nitric Oxide Synthase Type II, Prostaglandin-Endoperoxide Synthases - metabolism, Receptors, Cytoplasmic and Nuclear - metabolism, Stomach Neoplasms - etiology, Stomach Neoplasms - metabolism, Stomach Neoplasms - microbiology, Survival Rate, Transcription Factors - metabolism
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Laboratory Research
Comparative Evaluation of the Dimensional Accuracy of Silicone-Based Putty Reline Impressions with Differen...Med Sci Monit In Press; DOI: 10.12659/MSM.946537
Clinical Research
Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Oc...Med Sci Monit In Press; DOI: 10.12659/MSM.945937
Review article
COL3A1 Gene Polymorphism and Its Impact on Female Pelvic Organ ProlapseMed Sci Monit In Press; DOI: 10.12659/MSM.946367
Clinical Research
Quantifying Gait Asymmetry in Stroke Patients: A Statistical Parametric Mapping (SPM) ApproachMed Sci Monit In Press; DOI: 10.12659/MSM.946754
Most Viewed Current Articles
17 Jan 2024 : Review article 6,962,292
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 699,764
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 22,978
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 17,753
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912